- Home
- OWL vs ASND Comparison
OWL vs ASND Comparison
Compare OWL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OWL
- ASND
- Stock Information
- Founded
- OWL 2020
- ASND 2006
- Country
- OWL United States
- ASND Denmark
- Employees
- OWL N/A
- ASND 1017
- Industry
- OWL Investment Managers
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- OWL Finance
- ASND Health Care
- Exchange
- OWL Nasdaq
- ASND Nasdaq
- Market Cap
- OWL 10.6B
- ASND 12.2B
- IPO Year
- OWL N/A
- ASND 2015
- Fundamental
- Price
- OWL $15.77
- ASND $198.46
- Analyst Decision
- OWL Buy
- ASND Strong Buy
- Analyst Count
- OWL 15
- ASND 17
- Target Price
- OWL $22.50
- ASND $245.76
- AVG Volume (30 Days)
- OWL 14.7M
- ASND 407.0K
- Earning Date
- OWL 10-30-2025
- ASND 11-04-2025
- Dividend Yield
- OWL 5.75%
- ASND N/A
- EPS Growth
- OWL N/A
- ASND N/A
- EPS
- OWL 0.02
- ASND N/A
- Revenue
- OWL $2,745,943,000.00
- ASND $576,332,355.00
- Revenue This Year
- OWL $17.06
- ASND $104.98
- Revenue Next Year
- OWL $21.21
- ASND $79.91
- P/E Ratio
- OWL $888.36
- ASND N/A
- Revenue Growth
- OWL 27.24
- ASND 54.50
- 52 Week Low
- OWL $14.55
- ASND $118.03
- 52 Week High
- OWL $26.73
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- OWL 42.60
- ASND 46.50
- Support Level
- OWL $15.37
- ASND $195.03
- Resistance Level
- OWL $16.34
- ASND $208.39
- Average True Range (ATR)
- OWL 0.61
- ASND 8.60
- MACD
- OWL -0.02
- ASND -0.65
- Stochastic Oscillator
- OWL 29.48
- ASND 50.73
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.